NK T Cell Interactions with NK cells during Viral Infection
病毒感染期间 NK T 细胞与 NK 细胞的相互作用
基本信息
- 批准号:8112182
- 负责人:
- 金额:$ 25.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-15 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdjuvantAnimalsAntigen PresentationCD4 Positive T LymphocytesCD8B1 geneCategoriesCell CommunicationCellsCytomegalovirus InfectionsDendritic CellsGalactosylceramidesGenerationsGlycolipidsHepatocyteHourHumanImmuneImmune responseInfectionInjection of therapeutic agentInterleukin-12Interleukin-4LeadLigandsLiverLong-Term EffectsMediatingMolecularMurid herpesvirus 1MusNK Cell ActivationNatural Killer CellsOrganPhenotypePhysiologicalPropertyRoleSTAT1 geneShapesSignal TransductionStimulusT cell responseT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsVirusVirus Diseasescytokineinsightkiller T cellmacrophagenovelpathogenresponse
项目摘要
DESCRIPTION (provided by applicant): Natural killer T cells are a unique subset of T lymphocytes that rapidly produce Th1 and Th2 cytokines, most notably IFN-y and IL-4. NK T cells are CD4+CD8" or double negative and are dependent on a non-classical, non-polymorphic MHC class l-like molecule, CD1d, for positive selection, antigen presentation, and activation. Using the synthetic ligand, a-galactosylceramide (a- GalCer), we found that optimal NK T cell activation of NK cells requires a functional IFN-y signaling. The cross-talk between NK T cells and NK cells is indirect and mediated by macrophages and dendritic cells. To determine whether a cross-talk between NK T cells and NK cells occurs during a physiological stimulus, we used the murine cytomegalovirus (MCMV). This virus replicates in the murine liver, an organ particularly rich in NK cells and NK T cells as well as being characterized by high CD1d expression on hepatocytes. Upon MCMV infection, we have shown that NK T cells sense viral infection prior to NK cells in a STAT1 dependent manner and subsequently expand and synthesize cytokines. This early activation of NK T cells has an impact on the quality of both the innate and adaptive immune responses to the infection. Importantly, we found that the CD8+ T cell response to MCMV is impaired in NK T cell deficient animals. We therefore propose in the first Specific Aim to define the molecular and cellular mechanisms that lead to NK T cell activation of NK cells. In the second Aim, we propose to determine the NK T cell contribution to the innate and adaptive immune response to MCMV infection. In the third Aim, we propose to define a-GalCer adjuvant properties and to examine its long-term effects on NK T cell status in the context of a physiological stimulus. We believe that NK T cell activation has profound consequences in shaping both the innate and the adaptive immune response to pathogens. The novel studies proposed here will provide insight into the role of NK T cells during viral infection and may provide strategies for the manipulation of this important category of immune cell responses.
描述(由申请人提供):自然杀伤T细胞是T淋巴细胞的一个独特的亚群,可以快速产生Th1和Th2细胞因子,最显著的是IFN-y和IL-4。NK T细胞是CD4+CD8”或双阴性,依赖于非经典的、非多态性的MHC l类分子CD1d来进行阳性选择、抗原呈递和激活。使用合成配体a-半乳糖神经酰胺(a- GalCer),我们发现NK细胞的最佳NK T细胞激活需要功能性IFN-y信号。NK T细胞与NK细胞间的相互作用是间接的,由巨噬细胞和树突状细胞介导。为了确定NK T细胞和NK细胞之间是否在生理刺激中发生串扰,我们使用了小鼠巨细胞病毒(MCMV)。这种病毒在小鼠肝脏中复制,肝脏是一个特别富含NK细胞和NK T细胞的器官,其特点是肝细胞上CD1d的高表达。在MCMV感染后,我们已经证明NK T细胞以STAT1依赖的方式先于NK细胞感知病毒感染,随后扩增并合成细胞因子。这种NK T细胞的早期激活对感染的先天和适应性免疫反应的质量都有影响。重要的是,我们发现CD8+ T细胞对MCMV的反应在NK T细胞缺陷动物中受损。因此,我们在第一个特定目标中提出定义导致NK T细胞活化NK细胞的分子和细胞机制。在第二个目标中,我们建议确定NK T细胞对MCMV感染的先天和适应性免疫反应的贡献。在第三个目标中,我们建议定义a- galcer佐剂特性,并在生理刺激的背景下检查其对NK T细胞状态的长期影响。我们认为NK T细胞活化在形成先天和适应性免疫应答病原体方面具有深远的影响。本文提出的新研究将深入了解NK T细胞在病毒感染中的作用,并可能为操纵这一重要类型的免疫细胞反应提供策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurent Brossay其他文献
Laurent Brossay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurent Brossay', 18)}}的其他基金
Immune response to MCMV infection in the salivary glands
唾液腺对 MCMV 感染的免疫反应
- 批准号:
10735748 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Regulation of MCMV Persistence by Natural Killer Cells
自然杀伤细胞对 MCMV 持久性的调节
- 批准号:
9235250 - 财政年份:2016
- 资助金额:
$ 25.48万 - 项目类别:
NK T Cell Interactions with NK cells during Viral Infection
病毒感染期间 NK T 细胞与 NK 细胞的相互作用
- 批准号:
7799537 - 财政年份:2009
- 资助金额:
$ 25.48万 - 项目类别:
Functions of the KLRG1 molecule on NK cells and T cells
KLRG1分子对NK细胞和T细胞的功能
- 批准号:
7408608 - 财政年份:2004
- 资助金额:
$ 25.48万 - 项目类别:
Functions of the KLRG1 molecule on NK cells and T cells
KLRG1分子对NK细胞和T细胞的功能
- 批准号:
6825881 - 财政年份:2004
- 资助金额:
$ 25.48万 - 项目类别:
Functions of the KLRG1 molecule on NK cells and T cells
KLRG1分子对NK细胞和T细胞的功能
- 批准号:
6891598 - 财政年份:2004
- 资助金额:
$ 25.48万 - 项目类别:
Functions of the KLRG1 molecule on NK cells and T cells
KLRG1分子对NK细胞和T细胞的功能
- 批准号:
7056199 - 财政年份:2004
- 资助金额:
$ 25.48万 - 项目类别:
Functions of the KLRG1 molecule on NK cells and T cells
KLRG1分子对NK细胞和T细胞的功能
- 批准号:
7221914 - 财政年份:2004
- 资助金额:
$ 25.48万 - 项目类别:
Cadherins, Immune Receptors and their Interactions
钙粘蛋白、免疫受体及其相互作用
- 批准号:
8089039 - 财政年份:2003
- 资助金额:
$ 25.48万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 25.48万 - 项目类别: